Ally Bridge Group

Ally Bridge Group as of June 30, 2021

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 29 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Medavail Holdings Ord 8.9 $36M 2.9M 12.25
Spdr Ser Tr Put Put Option 6.7 $27M 200k 135.40
Natera (NTRA) 6.1 $25M 218k 113.53
Fate Therapeutics (FATE) 5.8 $23M 270k 86.79
Apellis Pharmaceuticals Call Call Option 4.7 $19M 300k 63.20
Syros Pharmaceuticals 4.7 $19M 3.4M 5.45
Arvinas Ord (ARVN) 4.6 $19M 240k 77.00
Cerevel Therapeutics Hldng I (CERE) 4.3 $17M 676k 25.62
Repligen Corporation (RGEN) 4.1 $17M 83k 199.62
Nuvation Bio Com Cl A (NUVB) 4.0 $16M 1.7M 9.31
Miragen Therapeutics (VRDN) 3.9 $16M 860k 18.29
Mirati Therapeutics 3.8 $15M 95k 161.53
Nautilus Biotechnology (NAUT) 3.8 $15M 1.5M 10.10
Intellia Therapeutics (NTLA) 3.7 $15M 93k 161.91
Cyteir Therapeutics 3.3 $13M 627k 21.40
Cogent Biosciences (COGT) 3.3 $13M 1.6M 8.11
Nanostring Technologies (NSTGQ) 3.0 $12M 185k 64.79
Ideaya Biosciences (IDYA) 2.7 $11M 510k 20.99
Iovance Biotherapeutics (IOVA) 2.6 $11M 407k 26.02
Essa Pharma Com New (EPIX) 2.6 $10M 363k 28.57
Invitae (NVTAQ) 2.5 $10M 300k 33.73
Gossamer Bio (GOSS) 2.4 $9.5M 1.2M 8.12
Atea Pharmaceuticals (AVIR) 2.0 $8.0M 373k 21.48
Bolt Biotherapeutics (BOLT) 1.6 $6.4M 412k 15.46
Apellis Pharmaceuticals (APLS) 1.3 $5.4M 85k 63.20
Adicet Bio (ACET) 1.1 $4.4M 425k 10.29
Silverback Therapeutics (SPRY) 1.0 $4.0M 129k 30.89
Freeline Therapeutics Hldgs Sponsored Ads 0.8 $3.3M 402k 8.15
Macrogenics (MGNX) 0.8 $3.0M 113k 26.86